Statin has been reported to have anti-inflammatory and immunomodulatory effects in an experimental mouse model of NMO by increasing CD55 expression (43), and our data also support that statin treatment on the disease courses has a significant correlation to outcomes. The gene discussed is CD55; the disease is neuromyelitis optica.